In our COVID-19 patients, therapeutic interventions (mostly glucocorticoids) leading to IL-6 normalization were associated with a rapid (median 7 days) and a significant reduction in QTc length (∼25 ms) and QTc prolongation frequency (lower by over 4 times), until reaching values similar to those in controls. Here, IL6 is linked to COVID-19.